These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 7073623)
21. Measles control in developing and developed countries: the case for a two-dose policy. Tulchinsky TH; Ginsberg GM; Abed Y; Angeles MT; Akukwe C; Bonn J Bull World Health Organ; 1993; 71(1):93-103. PubMed ID: 8440043 [TBL] [Abstract][Full Text] [Related]
22. Will the current measles vaccines ever eradicate measles? Stephenson J Expert Rev Vaccines; 2002 Oct; 1(3):355-62. PubMed ID: 12901574 [TBL] [Abstract][Full Text] [Related]
23. Late vaccination reinforcement during a measles epidemic in Niamey, Niger (2003-2004). Dubray C; Gervelmeyer A; Djibo A; Jeanne I; Fermon F; Soulier MH; Grais RF; Guerin PJ Vaccine; 2006 May; 24(18):3984-9. PubMed ID: 16540214 [TBL] [Abstract][Full Text] [Related]
24. Impact of mass measles campaigns among children less than 5 years old in Uganda. Nanyunja M; Lewis RF; Makumbi I; Seruyange R; Kabwongera E; Mugyenyi P; Talisuna A J Infect Dis; 2003 May; 187 Suppl 1():S63-8. PubMed ID: 12721893 [TBL] [Abstract][Full Text] [Related]
25. [Measles immunization and its problems]. Kökkaya A Mikrobiyol Bul; 1982 Jan; 16(1):66-70. PubMed ID: 7144618 [TBL] [Abstract][Full Text] [Related]
26. Measles in Ibadan: a continuous scourge. Lagunju IA; Orimadegun AE; Oyedemi DG Afr J Med Med Sci; 2005 Dec; 34(4):383-7. PubMed ID: 16752670 [TBL] [Abstract][Full Text] [Related]
27. Progress toward measles elimination--European Region, 2005--2008. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(6):142-5. PubMed ID: 19229166 [TBL] [Abstract][Full Text] [Related]
28. Measles incidence before and after supplementary vaccination activities--Lusaka, Zambia, 1996-2000. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Jun; 50(24):513-6. PubMed ID: 11432675 [TBL] [Abstract][Full Text] [Related]
29. Prevalence of measles antibodies before and after vaccination in previously unvaccinated children of the Cordillera Province (Santa Cruz Department, Bolivia). Guglielmetti P; Bianchi Bandinelli ML; Bartoloni A; Gamboa H; Roselli M; Valensin PE J Trop Med Hyg; 1994 Aug; 97(4):231-5. PubMed ID: 8064946 [TBL] [Abstract][Full Text] [Related]
30. [Survey of measles vaccine coverage in Brazzaville]. Bolanda D; Talani P; Nzaba P; Moudzeo H; Biahoua M; Mayanda H; Yala F Bull Soc Pathol Exot; 2000 Apr; 93(2):123-4. PubMed ID: 10863618 [TBL] [Abstract][Full Text] [Related]
31. Comparison of protection afforded by single measles vaccination and late revaccination schedules. Marufu T; Siziya S; Tshimanga M; Murugasampillay S; Mason E East Afr Med J; 1997 Dec; 74(12):777-9. PubMed ID: 9557421 [TBL] [Abstract][Full Text] [Related]
32. Measles epidemic in the Netherlands, 1999-2000. van den Hof S; Conyn-van Spaendonck MA; van Steenbergen JE J Infect Dis; 2002 Nov; 186(10):1483-6. PubMed ID: 12404165 [TBL] [Abstract][Full Text] [Related]
38. Importance of accurate diagnosis in the assessment of impact of immunisation campaigns: case study of a measles immunisation programme in Madagascar. Garry SF Public Health; 2009 Jan; 123(1):72-3. PubMed ID: 19049839 [No Abstract] [Full Text] [Related]
39. [The evolution of measles morbidity and mortality in Romania after the introduction of antimeasles vaccination]. Cazacu E; Bălan A; Dinică V Bacteriol Virusol Parazitol Epidemiol; 1994; 39(1-2):35-44. PubMed ID: 7981527 [No Abstract] [Full Text] [Related]